Bipartite Recognition of Target RNAs Activates DNA Cleavage by the Type III-B CRISPR-Cas System

Overview

Journal Genes Dev

Specialty Molecular Biology

Date 2016 Feb 6

PMID 26848045

Citations 127

Authors

Joshua R Elmore

Nolan F Sheppard

Nancy Ramia

Trace Deighan

Hong Li

Rebecca M Terns

Michael P Terns

Affiliations

Soon will be listed here.

Abstract

CRISPR-Cas systems eliminate nucleic acid invaders in bacteria and archaea. The effector complex of the Type III-B Cmr system cleaves invader RNAs recognized by the CRISPR RNA (crRNA ) of the complex. Here we show that invader RNAs also activate the Cmr complex to cleave DNA. As has been observed for other Type III systems, Cmr eliminates plasmid invaders in Pyrococcus furiosus by a mechanism that depends on transcription of the crRNA target sequence within the plasmid. Notably, we found that the target RNA per se induces DNA cleavage by the Cmr complex in vitro. DNA cleavage activity does not depend on cleavage of the target RNA but notably does require the presence of a short sequence adjacent to the target sequence within the activating target RNA (rPAM [RNA protospacer-adjacent motif]). The activated complex does not require a target sequence (or a PAM) in the DNA substrate. Plasmid elimination by the P. furiosus Cmr system also does not require the Csx1 (CRISPR-associated Rossman fold [CARF] superfamily) protein. Plasmid silencing depends on the HD nuclease and Palm domains of the Cmr2 (Cas10 superfamily) protein. The results establish the Cmr complex as a novel DNA nuclease activated by invader RNAs containing a crRNA target sequence and a rPAM.

Citing Articles

Mechanistic determinants and dynamics of cA6 synthesis in type III CRISPR-Cas effector complexes.

Jungfer K, Moravcik S, Garcia-Doval C, Knorlein A, Hall J, Jinek M Nucleic Acids Res. 2025; 53(2).

PMID: 39817514 PMC: 11734703. DOI: 10.1093/nar/gkae1277.

The influence of the copy number of invader on the fate of bacterial host cells in the antiviral defense by CRISPR-Cas10 DNases.

Yu Z, Xu J, Zhang Y, She Q Eng Microbiol. 2024; 3(4):100102.

PMID: 39628911 PMC: 11610955. DOI: 10.1016/j.engmic.2023.100102.

Cas10 relieves host growth arrest to facilitate spacer retention during type III-A CRISPR-Cas immunity.

Aviram N, Shilton A, Lyn N, Reis B, Brivanlou A, Marraffini L Cell Host Microbe. 2024; 32(12):2050-2062.e6.

PMID: 39626678 PMC: 11708336. DOI: 10.1016/j.chom.2024.11.005.

AcrIIIA1 is a protein-RNA anti-CRISPR complex that targets core Cas and accessory nucleases.

Chou-Zheng L, Howell O, Boyle T, Hossain M, Walker F, Sheriff E Nucleic Acids Res. 2024; 52(22):13490-13514.

PMID: 39551936 PMC: 11662646. DOI: 10.1093/nar/gkae1006.

Taxonomic Distribution, Phylogenetic Relationship, and Domain Conservation of CRISPR-Associated Cas Proteins.

Ranasinghe W, Gillette D, Ho A, Cho H, Choudhary M Bioinform Biol Insights. 2024; 18:11779322241274961.

PMID: 39397878 PMC: 11468465. DOI: 10.1177/11779322241274961.

References

Osawa T, Inanaga H, Sato C, Numata T . Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog. Mol Cell. 2015; 58(3):418-30. DOI: 10.1016/j.molcel.2015.03.018. View

Labrie S, Samson J, Moineau S . Bacteriophage resistance mechanisms. Nat Rev Microbiol. 2010; 8(5):317-27. DOI: 10.1038/nrmicro2315. View

Terns R, Terns M . The RNA- and DNA-targeting CRISPR-Cas immune systems of Pyrococcus furiosus. Biochem Soc Trans. 2013; 41(6):1416-21. PMC: 3996508. DOI: 10.1042/BST20130056. View

Staals R, Zhu Y, Taylor D, Kornfeld J, Sharma K, Barendregt A . RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus. Mol Cell. 2014; 56(4):518-30. PMC: 4342149. DOI: 10.1016/j.molcel.2014.10.005. View

Spilman M, Cocozaki A, Hale C, Shao Y, Ramia N, Terns R . Structure of an RNA silencing complex of the CRISPR-Cas immune system. Mol Cell. 2013; 52(1):146-52. PMC: 3864027. DOI: 10.1016/j.molcel.2013.09.008. View

Vestergaard G, Garrett R, Shah S . CRISPR adaptive immune systems of Archaea. RNA Biol. 2014; 11(2):156-67. PMC: 3973734. DOI: 10.4161/rna.27990. View

Ramia N, Tang L, Cocozaki A, Li H . Staphylococcus epidermidis Csm1 is a 3'-5' exonuclease. Nucleic Acids Res. 2013; 42(2):1129-38. PMC: 3902914. DOI: 10.1093/nar/gkt914. View

Shah S, Erdmann S, Mojica F, Garrett R . Protospacer recognition motifs: mixed identities and functional diversity. RNA Biol. 2013; 10(5):891-9. PMC: 3737346. DOI: 10.4161/rna.23764. View

Wiedenheft B, Lander G, Zhou K, Jore M, Brouns S, van der Oost J . Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature. 2011; 477(7365):486-489. PMC: 4165517. DOI: 10.1038/nature10402. View

10.

van der Oost J, Westra E, Jackson R, Wiedenheft B . Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat Rev Microbiol. 2014; 12(7):479-92. PMC: 4225775. DOI: 10.1038/nrmicro3279. View

11.

Hale C, Cocozaki A, Li H, Terns R, Terns M . Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex. Genes Dev. 2014; 28(21):2432-43. PMC: 4215187. DOI: 10.1101/gad.250712.114. View

12.

Zhang J, Rouillon C, Kerou M, Reeks J, Brugger K, Graham S . Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol Cell. 2012; 45(3):303-13. PMC: 3381847. DOI: 10.1016/j.molcel.2011.12.013. View

13.

Goldberg G, Jiang W, Bikard D, Marraffini L . Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature. 2014; 514(7524):633-7. PMC: 4214910. DOI: 10.1038/nature13637. View

14.

Tamulaitis G, Kazlauskiene M, Manakova E, Venclovas C, Nwokeoji A, Dickman M . Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus. Mol Cell. 2014; 56(4):506-17. DOI: 10.1016/j.molcel.2014.09.027. View

15.

Deng L, Garrett R, Shah S, Peng X, She Q . A novel interference mechanism by a type IIIB CRISPR-Cmr module in Sulfolobus. Mol Microbiol. 2013; 87(5):1088-99. DOI: 10.1111/mmi.12152. View

16.

Sinkunas T, Gasiunas G, Waghmare S, Dickman M, Barrangou R, Horvath P . In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus. EMBO J. 2013; 32(3):385-94. PMC: 3567492. DOI: 10.1038/emboj.2012.352. View

17.

Samai P, Pyenson N, Jiang W, Goldberg G, Hatoum-Aslan A, Marraffini L . Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity. Cell. 2015; 161(5):1164-1174. PMC: 4594840. DOI: 10.1016/j.cell.2015.04.027. View

18.

Ramia N, Spilman M, Tang L, Shao Y, Elmore J, Hale C . Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex. Cell Rep. 2014; 9(5):1610-1617. PMC: 4269474. DOI: 10.1016/j.celrep.2014.11.007. View

19.

Garrett R, Vestergaard G, Shah S . Archaeal CRISPR-based immune systems: exchangeable functional modules. Trends Microbiol. 2011; 19(11):549-56. DOI: 10.1016/j.tim.2011.08.002. View

20.

Makarova K, Grishin N, Shabalina S, Wolf Y, Koonin E . A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct. 2006; 1:7. PMC: 1462988. DOI: 10.1186/1745-6150-1-7. View